Your browser doesn't support javascript.
loading
Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure.
Tallaj, José A; Franco, Verónica; Rayburn, Barry K; Pinderski, Laura; Benza, Raymond L; Pamboukian, Salpy; Foley, Brian; Bourge, Robert C.
Affiliation
  • Tallaj JA; Department of Medicine, Birmingham VA Medical Center, Birmingham, Alabama 35294, USA. jtallaj@uab.edu
J Heart Lung Transplant ; 24(12): 2196-201, 2005 Dec.
Article in En | MEDLINE | ID: mdl-16364871
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Doxorubicin / Adrenergic beta-Antagonists / Antibiotics, Antineoplastic / Cardiomyopathies Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Heart Lung Transplant Journal subject: CARDIOLOGIA / TRANSPLANTE Year: 2005 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Doxorubicin / Adrenergic beta-Antagonists / Antibiotics, Antineoplastic / Cardiomyopathies Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Heart Lung Transplant Journal subject: CARDIOLOGIA / TRANSPLANTE Year: 2005 Document type: Article Affiliation country: Country of publication: